Skip to content

Clinical trials

Phase 3 Stroke trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 3 Country / region: Austria Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20055
20063
20071
20081
20091
20101
20112
20143
20151
20181
20191
20211
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated5
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Boehringer Ingelheim3
Bayer2
Sanofi2
AstraZeneca1
CSL Behring1
CoAxia1
Columbia University1
Eli Lilly and Company1
Ever Neuro Pharma GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke27
Ischemic Stroke6
Myocardial Infarction6
Cardiovascular Diseases5
Atrial Fibrillation4
Ischemia3
Ischemic Attack, Transient3
Acute Coronary Syndrome2
Atherosclerosis2
Coronary Artery Disease2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.